Brokerages Set Health Catalyst, Inc. (NASDAQ:HCAT) Price Target at $8.00

Shares of Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) have been given a consensus rating of "Moderate Buy" by the twelve ratings firms that are covering the firm, MarketBeat Ratings reports. Five analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $8.00.

A number of equities research analysts have recently issued reports on the stock. Citigroup dropped their target price on shares of Health Catalyst from $7.00 to $6.50 and set a "buy" rating for the company in a report on Friday, April 25th. Evercore ISI cut their price objective on shares of Health Catalyst from $5.00 to $4.00 and set an "in-line" rating for the company in a report on Wednesday. Stifel Nicolaus boosted their target price on Health Catalyst from $5.00 to $5.50 and gave the stock a "hold" rating in a report on Thursday, May 8th. Canaccord Genuity Group cut their price target on Health Catalyst from $10.00 to $9.00 and set a "buy" rating for the company in a report on Thursday, May 8th. Finally, BTIG Research lowered Health Catalyst from a "buy" rating to a "neutral" rating in a research note on Tuesday, June 17th.

Health Catalyst Stock Performance

Health Catalyst stock traded down $0.10 during midday trading on Tuesday, hitting $3.89. 274,239 shares of the company were exchanged, compared to its average volume of 612,212. The business has a fifty day simple moving average of $3.93 and a two-hundred day simple moving average of $4.69. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.24 and a current ratio of 1.24. The firm has a market capitalization of $270.74 million, a PE ratio of -3.38 and a beta of 1.51. Health Catalyst has a fifty-two week low of $3.49 and a fifty-two week high of $9.24.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the stock. Quantbot Technologies LP acquired a new position in shares of Health Catalyst in the 4th quarter worth approximately $29,000. Group One Trading LLC raised its position in Health Catalyst by 107.6% in the fourth quarter. Group One Trading LLC now owns 4,360 shares of the company's stock valued at $31,000 after purchasing an additional 2,260 shares during the period. Aquatic Capital Management LLC acquired a new position in Health Catalyst during the fourth quarter worth $63,000. Focus Partners Wealth purchased a new position in shares of Health Catalyst during the first quarter worth $46,000. Finally, Martin Worley Group acquired a new stake in shares of Health Catalyst in the fourth quarter valued at $78,000. Hedge funds and other institutional investors own 85.00% of the company's stock.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.